Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GDRX

GoodRx Holdings Inc

Mar 26 • 04:00PM ET

4.54

Dollar change -0.01
Percentage change -0.22	%

Healthcare • Health Information Services • USA • NASD

Peers: AMZN UNH MCK CVS CI WBA HUM LH DGX CAH

| Held by: VTI VB VXF VBK KOMP SCHA VHT DFAT DFAS EES

Scroll to Statements

Index	-	P/E	106.57	EPS (ttm)	0.04	Insider Own	76.83%	Shs Outstand	105.95M	Perf Week	-5.22%
Market Cap	1.74B	Forward P/E	9.72	EPS next Y	0.47	Insider Trans	0.00%	Shs Float	88.88M	Perf Month	-2.37%
Income	16.39M	PEG	6.55	EPS next Q	0.09	Inst Own	16.15%	Short Float	6.46%	Perf Quarter	2.25%
Sales	792.32M	P/S	2.20	EPS this Y	13.45%	Inst Trans	-23.19%	Short Ratio	3.95	Perf Half Y	-32.54%
Book/sh	1.89	P/B	2.40	EPS next Y	21.14%	ROA	1.10%	Short Interest	5.74M	Perf Year	-31.00%
Cash/sh	1.17	P/C	3.88	EPS next 5Y	16.26%	ROE	2.21%	52W Range	4.09 - 9.26	Perf YTD	-2.37%
Dividend Est.	-	P/FCF	9.54	EPS past 5Y	-17.73%	ROI	1.30%	52W High	-50.97%	Beta	1.26
Dividend TTM	-	Quick Ratio	5.32	Sales past 5Y	16.71%	Gross Margin	85.14%	52W Low	11.00%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	5.32	EPS Y/Y TTM	291.59%	Oper. Margin	11.15%	RSI (14)	44.92	Volatility	4.61% 5.93%
Employees	738	Debt/Eq	0.75	Sales Y/Y TTM	5.61%	Profit Margin	2.07%	Recom	2.00	Target Price	6.71
Option/Short	Yes / Yes	LT Debt/Eq	0.74	EPS Q/Q	127.41%	Payout	0.00%	Rel Volume	0.70	Prev Close	4.55
Sales Surprise	-0.59%	EPS Surprise	-1.32%	Sales Q/Q	0.99%	Earnings	Feb 27 BMO	Avg Volume	1.45M	Price	4.54
SMA20	-2.48%	SMA50	-4.29%	SMA200	-27.11%	Trades		Volume	1,015,822	Change	-0.22%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-24	Initiated	Mizuho	Neutral	$5
Aug-09-24	Upgrade	Raymond James	Outperform → Strong Buy	$10
May-23-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$8 → $10
May-16-24	Upgrade	Raymond James	Mkt Perform → Outperform	$10
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$9
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$7.50 → $10
Mar-01-24	Upgrade	JP Morgan	Neutral → Overweight	$7 → $10
Feb-26-24	Initiated	Leerink Partners	Outperform	$8
Jan-02-24	Downgrade	BofA Securities	Buy → Underperform	$8 → $4.50
Aug-10-23	Upgrade	DA Davidson	Neutral → Buy	$9.50
Jul-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$6.50 → $12
Dec-01-22	Initiated	Citigroup	Buy	$7
Nov-04-22	Upgrade	JP Morgan	Underweight → Neutral	$10 → $8
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$6.50
Aug-12-22	Initiated	DA Davidson	Neutral	$8
Jun-10-22	Downgrade	Goldman	Buy → Neutral	$12 → $9
Jun-06-22	Resumed	BofA Securities	Buy	$11
Jun-01-22	Downgrade	Robert W. Baird	Outperform → Neutral	$10 → $7
May-10-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10

Show Previous Ratings

Mar-25-25 12:00PM	GoodRx Joins NCPDP's Elite Partner Program, Demonstrating Long-Term Commitment to Advancing Healthcare Standards (PR Newswire)
Mar-24-25 04:16PM	GoodRx: Great Value For Patient Investors (Upgrade) (SeekingAlpha)
Mar-17-25 09:03AM	3 Small-Cap Stocks in Hot Water (StockStory)
09:00AM	GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement (Business Wire)
Mar-12-25 09:03AM	3 Stocks Under $10 Skating on Thin Ice (StockStory)
09:33AM	Loading…
Mar-10-25 09:33AM	GoodRx Holdings, Inc. (GDRX): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
09:00AM	GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending (Business Wire)
Mar-07-25 03:08AM	GoodRx Holdings, Inc. (GDRX): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Feb-28-25 02:10AM	GoodRx Holdings Inc (GDRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-27-25 03:15PM	GoodRx (GDRX) Q4 2024 Earnings Call Transcript (Motley Fool)
09:30AM	Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings (Zacks)
07:20AM	GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates (Zacks)
06:34AM	GoodRx (NASDAQ:GDRX) Misses Q4 Revenue Estimates (StockStory)
06:05AM	GoodRx Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-26-25 08:04AM	GoodRx Earnings: What To Look For From GDRX (StockStory) +5.16%
07:37AM	Loading…
07:37AM	GoodRx Holdings Inc (GDRX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-25-25 09:15AM	Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key Metrics (Zacks)
Feb-19-25 05:23PM	'Health insurance companies are always going to need a PBM': CVS president Prem Shah (Yahoo Finance) -5.26%
Feb-18-25 04:51PM	White House targets PBM reform as drug pricing concerns escalate (Yahoo Finance Video)
09:00AM	GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats (Business Wire)
Feb-17-25 08:12AM	1 Healthcare Stock Primed for Growth and 2 to Avoid (StockStory)
07:34AM	1 Healthcare Stock Primed for Growth and 2 to Snub (StockStory)
Feb-12-25 08:20PM	What can we learn from insulin price reductions (FastCompany)
Feb-07-25 04:39AM	GoodRx names new CFO (Healthcare Dive)
Feb-05-25 04:05PM	GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer (Business Wire)
Jan-30-25 04:05PM	GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (Business Wire)
Jan-27-25 07:08AM	Is GoodRx Holdings (GDRX) the Best Affordable Stock Under $5 to Buy Now? (Insider Monkey)
Jan-22-25 05:00PM	Scott Wagner Joins GoodRx Board of Directors (Business Wire)
Jan-16-25 07:37AM	JP Morgan 2025: GoodRx takes aim at US drug pricing challenges (Pharmaceutical Technology)
Jan-10-25 11:00AM	GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires (Business Wire) +6.31%
09:00AM	Loading…
Jan-07-25 09:00AM	GoodRx Unleashes GoodRx for Pets, Simplifying Access and Reducing Costs for Pet Medications (Business Wire)
Jan-06-25 09:00AM	WM Technology, Inc. Names Sarah Griffis Chief Technology Officer (Business Wire)
Dec-18-24 04:05PM	GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-17-24 09:00AM	GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties (Business Wire)
07:31AM	GoodRx appoints former PBM exec as permanent CEO (Healthcare Dive)
Dec-16-24 04:05PM	GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer (Business Wire)
Dec-11-24 02:04AM	Is GoodRx Holdings (GDRX) the Best NASDAQ Penny Stock to Buy Right Now? (Insider Monkey)
Dec-05-24 11:13AM	Wegovy and Zepbound are leading this year's weight loss drug prescription surge (Quartz)
09:00AM	GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged (Business Wire)
Nov-13-24 07:00AM	Harrow Launches Access and Affordability Program with Price Reductions for Branded Products (Business Wire)
Nov-08-24 07:15AM	Why GoodRx Holdings Stock Was Sinking This Week (Motley Fool)
02:10AM	GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... (GuruFocus.com)
Nov-07-24 11:45PM	GoodRx (GDRX) Q3 2024 Earnings Call Transcript (Motley Fool) -17.51%
09:30AM	GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:25AM	GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates (Zacks)
06:05AM	GoodRx Reports Third Quarter 2024 Results (Business Wire)
Nov-06-24 09:15AM	GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
07:15AM	GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-04-24 04:05PM	GoodRx to Participate in Upcoming Investor Conferences (Business Wire) -5.17%
Oct-31-24 09:00AM	GoodRx Unveils New E-commerce Platform, Launches with Opill (Business Wire)
Oct-29-24 09:46AM	GoodRx stock moves on exclusive 30-day offer of weight management drug Qsymia (Investing.com)
09:00AM	GoodRx Announces Exclusive Low Cash Price for QSYMIA, the Leading Branded Once-Daily Oral Weight Management Medication for Adults (Business Wire)
Oct-28-24 08:00AM	Ronald E. Bruehlman Joins GoodRx Board of Directors (Business Wire)
Oct-23-24 09:00AM	GoodRx Announces New Affordability Programs for Menopause Hormone Therapies (Business Wire)
Oct-16-24 09:00AM	GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers (Business Wire)
Oct-10-24 05:41PM	GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call (Business Wire)
03:04PM	BANK OF NOVA SCOTIA's Strategic Acquisition in GoodRx Holdings Inc (GuruFocus.com)
03:04PM	BANK OF NOVA SCOTIA's Strategic Acquisition of GoodRx Holdings Inc Shares (GuruFocus.com)
Oct-09-24 05:33PM	GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges (GuruFocus.com)
Sep-26-24 09:00AM	GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy (epinephrine nasal spray) (Business Wire)
Sep-06-24 04:52PM	Why Big Pharma is betting on telehealth strategies (Yahoo Finance)
Aug-30-24 04:31AM	Notice to Long-Term Investors of GoodRx Holdings, Inc. (GDRX): Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile)
Aug-21-24 04:05PM	GoodRx to Participate in Upcoming Investor Conferences (Business Wire)
06:00AM	Employer health care costs expected to jump 9% in US next year (Fox Business)
Aug-14-24 07:02PM	Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc ... (GuruFocus.com)
Aug-09-24 03:29AM	Q2 2024 GoodRx Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-08-24 03:45PM	GoodRx (GDRX) Q2 2024 Earnings Call Transcript (Motley Fool) -18.58%
09:30AM	GoodRx (GDRX) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue Estimates (Zacks)
06:05AM	GoodRx Reports Second Quarter 2024 Results (Business Wire)
Aug-06-24 09:15AM	Unveiling GoodRx (GDRX) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks) +5.94%
Jul-25-24 06:00AM	Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future (News Direct)
Jul-19-24 11:13AM	Boehringer Ingelheim offers Humira biosimilar at 92% discount (Pharmaceutical Technology) +5.46%
Jul-18-24 06:00AM	GoodRx partners with Boehringer Ingelheim to discount Humira biosimilar (Yahoo Finance)
06:00AM	Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira (PR Newswire)
Jul-11-24 09:00AM	GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call (Business Wire)
Jul-10-24 09:00AM	Ian T. Clark Joins GoodRx Board of Directors (Business Wire)
06:30AM	3 Lawsuit-Laden Stocks to Dump Before Problems Multiply (InvestorPlace)
Jun-28-24 08:00AM	Market Correction Alert: Sell These 3 Tech Stocks While You Can (InvestorPlace)
Jun-26-24 09:00AM	GoodRx Launches New Prescription Cost Tracker to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S. (Business Wire)
Jun-17-24 06:30AM	3 Stocks to Sell ASAP Before the June 27 Presidential Debate (InvestorPlace)
Jun-14-24 05:45AM	Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights - GDRX (PR Newswire)
Jun-04-24 06:30AM	The 3 Most Undervalued Under-$10 Stocks to Buy in June 2024 (InvestorPlace)
May-30-24 04:05PM	Simon Patterson Joins GoodRx Board of Directors (Business Wire)
08:35AM	GoodRx Named One of the 2024 TIME100 Most Influential Companies (Business Wire)
May-26-24 12:51AM	Street calls of the week: Upgrades for Micron, Magnite and GoodRx Holdings (Investing.com)
May-23-24 03:34PM	Top Stock Movers Now: Nvidia, Boeing, Live Nation Entertainment, and More (Investopedia)
May-22-24 09:00AM	GoodRx Offers Discounts of Up to 43% On Fertility Treatments (Business Wire)
May-20-24 10:14AM	Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating (MT Newswires)
May-17-24 10:25AM	UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating (MT Newswires) -7.20%
08:54AM	Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating (MT Newswires)
May-16-24 11:11AM	GoodRx Shares Rise After Raymond James Upgrade (MT Newswires) +10.87%
09:51AM	Intel upgraded, Texas Instruments initiated: Wall Street's top analyst calls (The Fly)
07:10AM	Raymond James Upgrades GoodRx Holdings to Outperform From Market Perform (MT Newswires)
May-15-24 12:01PM	Update: GoodRx Signs Direct Contracting Agreement With Kroger; GoodRx Shares Rise (MT Newswires) +9.32%
09:12AM	Sector Update: Health Care Stocks Rise Pre-Bell Wednesday (MT Newswires)
06:48AM	GoodRx Signs Direct Contracting Agreement With Kroger (MT Newswires)
06:00AM	GoodRx and Kroger Sign Direct Contracting Agreement (Business Wire)
May-14-24 02:25PM	Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights GDRX (GlobeNewswire)
May-13-24 07:27AM	Deutsche Bank Adjusts GoodRx Price Target to $8 From $9, Maintains Hold Rating (MT Newswires)

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kennedy Kelly J.	Director	Dec 21 '24	Option Exercise	4.44	23,150	102,786	54,012	Dec 23 05:31 PM
Bradley Julie MB	Director	Dec 02 '24	Proposed Sale	4.95	95,255	471,451		Dec 02 07:06 PM
Spectrum Equity VII, L.P.	10% Owner	Sep 03 '24	Sale	7.86	10,677	83,922	0	Sep 03 06:05 PM
Spectrum VII Investment Manage	Affiliate	Sep 03 '24	Proposed Sale	7.86	6,828	53,668		Sep 03 04:44 PM
Spectrum VII Co-Investment Fun	Affiliate	Sep 03 '24	Proposed Sale	7.86	3,849	30,253		Sep 03 04:43 PM
Nabiey Romin	Chief Accounting Officer	Aug 12 '24	Sale	6.77	79,000	534,625	64,633	Aug 14 04:40 PM
ROMIN NABIEY	Officer	Aug 12 '24	Proposed Sale	6.77	79,000	534,625		Aug 12 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GDRX

GoodRx Holdings Inc

Upgrade your FINVIZ experience